glucagon has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hölscher, C; Li, L; Li, Y; Liu, W; Tai, J | 1 |
| Bos, E; Carlotti, F; Clark, A; de Koning, EJ; Ellenbroek, JH; Engelse, MA; Hansen, BC; Koster, AJ; Rabelink, TJ; Roefs, MM; Song, H; Spijker, HS | 1 |
2 other study(ies) available for glucagon and Amyloid Deposits
| Article | Year |
|---|---|
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hippocampus; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Presenilin-1; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 2018 |
Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Humans; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Macaca fascicularis; Macaca mulatta; Male; Plaque, Amyloid | 2015 |